Phase 2Recruiting

Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial (Psi or Ket)

Psilocybin vs Ketamine for Alcohol Use Disorder

Sponsor
University of Iowa (Academic or other)
Enrollment
80 planned
Conditions
Alcohol Use Disorder; Alcohol Dependence; Alcohol Abuse
Interventions
Psilocybin; Ketamine
Ages
adults, older adults
Registry
NCT06405607

Full record on ClinicalTrials.gov

From the registry

This study will collect data that measures the effects of a psychedelic intervention on patients struggling with alcohol use disorder (AUD). The study design will be a double blind, randomized, active-comparator trial with two study arms. Subjects randomized to Arm 1 (n=40) will receive individual psychotherapy sessions plus a 30 mg dose of psilocybin. Arm 2 subjects (n=40) will receive individual psychotherapy sessions and a 0.75 mg/kg dose of ketamine.

Primary outcomes

  • Timeline Follow-Back for Alcohol to assess change

History

  1. Primary completion expected

  2. Last registry update

  3. Started

  4. Registered